# NGA-01 Gel for the Treatment of Osteoarthritis With Joint Pain

> **NCT04612283** · PHASE2,PHASE3 · COMPLETED · sponsor: **Nutrin GmbH** · enrollment: 60 (actual)

## Conditions studied

- Arthritis Osteoarthritis

## Interventions

- **OTHER:** NGA-01 gel
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04612283
- **Lead sponsor:** Nutrin GmbH
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-31
- **Primary completion:** 2022-01-15
- **Final completion:** 2022-01-25
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-01-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04612283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04612283, "NGA-01 Gel for the Treatment of Osteoarthritis With Joint Pain". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04612283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*